Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer.

The technique to analyze circulating tumor DNA (ctDNA) in body fluid (so-called “liquid biopsy”) is recently developed.Our aim was to assess the utility of liquid biopsy for predicting progression ...